{"id":"W2115528152","doi":"10.1016/s1470-2045(15)00038-8","title":"Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Astex Pharmaceuticals; National Cancer Institute; Stand Up To Cancer; Entertainment Industry Foundation","keywords":"Tolerability; Medicine; Decitabine; International Prognostic Scoring System; Internal medicine; Hypomethylating agent; Myelodysplastic syndromes; Adverse effect; Neutropenia; Febrile neutropenia; Oncology; Pharmacology; Gastroenterology; Bone marrow; Toxicity; Biology; DNA methylation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001329233,0.001487682,0.002448973,0.0003332464,0.0002516468,0.0008581243,0.0006926499,0.001410845,0.00256892],"category_scores_gemma":[0.001242791,0.0007943091,0.001396638,0.0004212107,0.001227689,0.0009259295,0.0003453159,0.0027775,0.0006811733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001054763,"about_ca_system_score_gemma":0.0009415738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009983268,"about_ca_topic_score_gemma":0.002136624,"domain_scores_codex":[0.9994271,0.0003109783,0.00002925824,0.00008707817,0.00004709545,0.00009850278],"domain_scores_gemma":[0.9992927,0.0001585631,0.0001735988,0.00006282907,0.00003863087,0.000273705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9452592,0.008773699,0.002067484,0.0004538096,0.0009523616,0.00007044453,0.0001151487,0.001041362,0.01178553,0.00009325142,0.0008807216,0.02850707],"study_design_scores_gemma":[0.7916769,0.1976286,0.00727274,0.00002160028,0.0004750847,0.0001025198,0.00004419154,0.0007021996,0.001201345,0.0001387497,0.0007053725,0.0000308959],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969983,0.001240656,0.0002003664,0.0001891043,0.00007294903,0.0005001877,0.0003474432,0.00003956122,0.0004114972],"genre_scores_gemma":[0.996017,0.0009268173,0.0005557384,0.0004234022,0.00006724582,0.0004951957,0.0006361181,0.00001618477,0.0008622517],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00256892,"threshold_uncertainty_score":0.008593917,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02983554464073441,"score_gpt":0.3333968728278118,"score_spread":0.3035613281870774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}